Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Salud y Vida 2.0: Enhancing Integrated Behavioral Health for Individuals With Diabetes in the Rio Grande Valley
The purpose of this study is to implement a system of integrated health care that provides a continuum of care for those with diabetes. This study will use a randomized behavioral intervention trial experimental design to compare participants receiving the enhanced delivery of integrated behavioral care with nonparticipants receiving the usual care until after the study period, at which time they will be offered access to expansion services.
The Rio Grande Valley (RGV), located on the northern bank of the Rio Grande River that
separates the United States from Mexico, is home to more than 1.2 million residents,
representing about 5% of Texas' general population. The SyV 2.0 program focuses on the system
of health care in the lower RGV, comprised of a predominantly Mexican American, low-income,
underserved community with chronic disease rates and related mortality that exceed those in
most other regions of the state and the nation. Based on a cohort study of 2,000 Mexican
American adults from this region between 2003 to 2008 called the Cameron County Hispanic
Cohort (CCHC), researchers estimated diabetes prevalence to be 31% and 81% of the population
were either obese (49%) or overweight (32%). Residents in this region suffer from
disproportionate health disparities that stem from extreme poverty (40% of families live
below federal poverty line), lower levels of educational attainment (9.9 average years of
education), and inadequate access to basic health care needs, income, and education.
The SyV 2.0 program is an expansion of SyV 1.0, a program for individuals with uncontrolled
diabetes. Enhancement includes two major initiatives: clinical-based services and
community-based services. Clinical based services will include medication therapy management
for participants with low levels of medication adherence and care coordination which includes
behavioral health services for participants who do not qualify for services with the mental
health authority, but need behavioral health support. Community-based services will include
peer led support groups and access to community-based lifestyle programs (capacity building
cooking classes and an obesity awareness program). Clinical-based and community-based
services will be directed by a multidisciplinary care team and will be customized to meet
each participant's individualized needs.
The proposed study does not pose any major risks or dangers beyond what a normal physician
visit would present. Benefits include improved control of chronic disease (diabetes,
hypertension, and obesity), a reduction in depression, increased access to behavioral
healthcare services, and improved adult functioning and quality of life for current SyV 1.0
participants.
This study will contribute to the investigator's understanding of how to increase access to
health care services and treatment among those individuals with diabetes, namely, low-income,
Hispanic communities.
- This study was not funded by the National Institutes of Health (NIH). It was funded by
two Texas foundations, Methodist Healthcare Ministries and Valley Baptist Legacy
Foundation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |